Zdrowie i gospodarka · 12/09/2008
FDA Opens Public Docket for Comments on LASIK Devices
The FDA is seeking public input on the post-market experience of LASIK devices, including laser-assisted in situ keratomileusis (LASIK) devices, to inform the establishment of a new regulatory framework.
Source: Federal Register — Food and Drug AdministrationOpen original release →